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ABSTRACT
Background Serological studies indicate that evidence
of coeliac disease (CD) exists in about 1% of all
children, but we lack estimates of current diagnostic
patterns among children and how they vary by
socioeconomic group.
Methods We identiﬁed all children aged 0–18 years
between 1993 and 2012 who were registered with
general practices across the UK that contribute to a large
population-based general practice database. The
incidence of CD was evaluated in each quintile of the
Townsend index of deprivation and stratiﬁed by age, sex,
country and calendar year.
Results Among 2 063 421 children, we identiﬁed
1247 CD diagnoses, corresponding to an overall CD
incidence of 11.9 per 100 000 person-years, which was
similar across the UK countries and higher in girls than
in boys. We found a gradient of CD diagnosis across
socioeconomic groups, with the rate of diagnosis being
80% higher in children from the least-deprived areas
than in those from the most-deprived areas (incident rate
ratio 1.80, 95% CI 1.45 to 2.22). This pattern held for
both boys and girls and across all ages. Across all four
countries of the UK, we found similar associations
between CD and socioeconomic status. While CD
incidence up to age 2 remained stable over the study
period, diagnoses at older ages have almost tripled over
the past 20 years.
Conclusions Children living in less socioeconomically
deprived areas in the UK are more likely to be diagnosed
with CD. Increased implementation of diagnostic
guidelines could result in better case identiﬁcation in
more-deprived areas.
INTRODUCTION
Screening studies among children in the USA and
Western Europe report a seroprevalence of coeliac
disease (CD) of around 1%.1–6 However, over the
last two decades, several studies have reported an
increased incidence of biopsy-detected CD in chil-
dren,7 the reason for which is unclear. One explan-
ation for the increase is that it represents improved
ascertainment due to heightened clinical awareness
underpinned by improved accuracy and availability
of diagnostic tests8 and/or to screening programmes
in people with associated diseases.9 If this increase
in clinically diagnosed paediatric CD does only rep-
resent improved ascertainment, then one might
expect it to be more marked in higher socio-
economic groups. This is because children of
higher socioeconomic status are more likely to seek
healthcare,10 and therefore opportunities for inves-
tigation in so-called ‘at-risk’ groups would be
expected to occur more frequently among them,
which may lead to more frequent testing for CD.11
The few studies that have investigated a possible
socioeconomic gradient in CD have reported con-
ﬂicting results.12–21 In view of this and the lack of
population-based studies, assessing patterns of clin-
ical diagnosis of CD among children in the UK, we
examined the incidence of CD up to 18 years of
age and its variation by socioeconomic group,
taking into account age, sex, calendar period and
country within the UK.
METHODS
Data were obtained from The Health Improvement
Network (THIN), a nationally representative UK
database of primary care records, containing
medical diagnoses, events and drug prescriptions.22
Our cohort was all children aged 0–18 years regis-
tered with a THIN general practice (GP) at any time
from 1 January 1993 to 31 December 2012. We
identiﬁed all incident diagnoses of CD based on the
presence of one or more of the following Read
codes recorded in children’s GP records: J690.00-
Coeliac disease, J690.13-Gluten enteropathy,
J690z00-Coeliac disease NOS. For patients with
more than one CD code, the earliest was considered
as the date of disease diagnosis. Children with CD
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What is already known on this topic?
▸ Serological studies indicate that evidence of
coeliac disease exists in about 1% of all
children yet clinical diagnoses are much less
prevalent.
▸ Existing studies on the socio-demographic
distribution of childhood clinically diagnosed
coeliac disease are in small study populations
and ﬁndings are contradictory.
What this study adds?
▸ Clinical diagnoses of coeliac disease among
children aged over 2 years have almost tripled
over the last two decades.
▸ Children from the most socioeconomically
deprived areas are only half as likely to be
diagnosed with coeliac disease as those from
less-deprived areas.
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recorded before their entry date were considered to have preva-
lent disease and were thus excluded.
The incidence of CD per 100 000 person-years was calculated
by dividing the number of children with CD by the total
follow-up time contributed to the study period by all children.
Incidence was stratiﬁed by age, sex, country of residence
(England, Scotland, Wales and Northern Ireland), calendar year
(grouped as quinquennia) and household socioeconomic quin-
tile, measured by the Townsend index.23 Townsend index mea-
sures area-level (approximately 50 households) deprivation
based on local unemployment, car ownership, overcrowding
and home ownership from the 2001 Census; use of quintiles
maintains anonymity.
Poisson regression was used to calculate unadjusted incidence
rate ratios (IRRs) for CD by all factors, and potential interac-
tions were assessed using the likelihood ratio test (LRT). Age
was grouped into three age bands (0–2, 3–9, 10–18), similar to
that in previous demographic studies of CD.17 24 25 Although
prevalent CD cases had been excluded, children with a ﬁrst
diagnosis recorded soon after their GP registration may have
had prevalent disease upon study entry (diagnosed before but
recorded near the time of GP registration). Therefore, we con-
ducted a sensitivity analysis excluding patients whose ﬁrst CD
diagnosis or gluten-free product prescription was recorded
within 6 months of initial registration unless they were diag-
nosed at younger than age 2 years. This method of excluding
potentially prevalent cases was based on Lewis et al’s26 but tai-
lored to children since diagnoses very early in life are likely to
be incident regardless of proximity to registration. We con-
ducted a second sensitivity analysis to exclude potential CD
overestimation using a restricted CD deﬁnition where cases had
to have at least one gluten-free product prescription associated
with their CD diagnosis. In the UK, children with CD are eli-
gible to receive free prescriptions from their GP to purchase
gluten-free foods, funded by the public National Health Service.
While patients with CD are not required to obtain these pre-
scriptions, they would not be received unless a deﬁnitive CD
diagnosis was made. Analyses were performed using Stata V.12.
RESULTS
There were 2 063 421 children in our study population, contrib-
uting a total of 10 508 374 person-years. Their median
follow-up was 3.8 years (IQR 1.5–7.9) and 1247 children were
diagnosed with CD, corresponding to an overall incidence rate
of 11.9 per 100 000 person-years.
Socio-demographic distribution of CD diagnoses
Table 1 shows variations in the rate of CD diagnosis by sex, age,
country, calendar period and socioeconomic deprivation. The
rate of CD in girls was 53% higher (IRR 1.53, 95% CI 1.37 to
1.72) than in boys. Incidence varied by age with the lowest CD
in children younger than 1 after which it increased to 18.7 and
17.9 per 100 000 person-years at ages 1 and 2 years, respect-
ively. Incidence then decreased, ranging between 8.4 and 15.1
per 100 000 person-years between ages 3 and 18 years. We did
not ﬁnd signiﬁcant geographic variation across the UK, with a
similar CD incidence observed in the four countries. Across the
20-year period studied, there was a clear increase with a CD
diagnosis rate in the last ﬁve years (2008–2012) that was 75%
higher than in 1993–1997 (IRR 1.75, 95% CI 1.31 to 2.34).
Table 2 shows how the incidence of CD varied by sex, age
and country over the study period. There was a 39% increase in
boys (IRR 1.39, 95% CI 0.92 to 2.10) and a twofold increase in
girls (IRR 2.09, 95% CI 1.39 to 3.13). However, there was no
statistically signiﬁcant interaction between sex and calendar
period (LRT p value for interaction=0.4). Conversely, across
the three age groups studied, there was a statistically signiﬁcant
interaction with calendar period (LRT p<0.001). Children aged
0–2 years had a roughly constant CD incidence over time,
whereas children aged 3–18 years had threefold increase from
1993–1997 to 2008–2012 periods. CD incidence increased
over time in England and Scotland, while we did not observe a
statistically signiﬁcantly increase in Wales and Northern Ireland.
Incident CD diagnoses across socioeconomic status
We found a gradient across socioeconomic groups in CD diag-
noses, with the highest CD incidence in children from the two
least socioeconomically deprived areas, followed by a progres-
sive reduction of CD incidence in the latter three quintiles
(table 1). The lowest incidence was in the most socioeconomic-
ally deprived areas. Tables 3 and 4 show, respectively, the abso-
lute rate of CD and the adjusted IRRs for the association of CD
with socioeconomic status, stratiﬁed by sex, age, calendar period
and country. We observed a similar relationship between socio-
economic status and CD in both sexes, in all age groups, over
time, and in all countries (all LRTs not statistically signiﬁcant for
interaction between these variables and socioeconomic status).
There was a statistically signiﬁcant socioeconomic gradient in
each time period other than 1993–1997, when the highest inci-
dence rate was observed in the third quintile. Moreover,
although we did not ﬁnd a statistically signiﬁcant socioeconomic
trend in CD in smaller populations from Wales and Northern
Ireland, they also had the highest incidence rate of CD in chil-
dren from the least socioeconomically deprived areas and the
lowest CD incidence rate in children from more socioeconomic-
ally deprived areas, in the 5th and 4th quintiles, respectively
(ﬁgure 1).
Sensitivity analyses
There were 230 children diagnosed with CD after 2 years of age
with a ﬁrst CD record or gluten-free prescription within
6 months of GP registration (18.4% potentially prevalent cases
out of the total 1247 case population). After excluding these
potentially prevalent cases, the overall incidence was 9.7 per
100 000 person-years. Variations between subgroups, however,
remained similar to the main analyses (see online supplementary
table S1). After restricting our CD cases to children with a
gluten-free product prescription, there were 1007 children
(80.8% of the total 1247 case population), resulting in an inci-
dence of 9.6 per 100 000 person-years. Again, IRRs remained
similar to main analyses, showing the same incidence patterns
by sex, age, calendar time, country and socioeconomic status
(see online supplementary table S2).
DISCUSSION
Main ﬁndings
The overall CD incidence of 11.9 per 100 000 person-years was
similar across the UK countries and higher in girls than in boys.
While CD incidence up to age 2 remained stable over time,
diagnoses in older children have almost tripled over the past
20 years. We found a strong socioeconomic gradient in CD diag-
noses such that children living in less socioeconomically
deprived areas were about twice as likely to be diagnosed as
those in more-deprived areas. This pattern held for boys and
girls and for all ages. Across all four countries, we found evi-
dence of a similar socioeconomic gradient in CD diagnosis.
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Strengths and limitations
This is the largest study of childhood CD in which the possible
role of socio-demographic aspects on the rate of CD diagnosis
has been examined. The demographics of our study population
are comparable to those of children in the UK population,27 so
our ﬁndings are likely to be representative of this population.
We considered CD diagnosis by using a physician’s report as
recorded in GP as we did not have comprehensive information
on serological or histological testing for each patient. While our
pragmatic approach may have resulted in false-positive cases,
the accuracy of CD recording in primary care was speciﬁcally
validated against medical records28 in a small sample of patients,
showing a good concordance between paper and electronic
records. We used a single diagnostic code to maximise the sensi-
tivity in the main analysis, but when we used a more speciﬁc
case deﬁnition (including only children with at least one CD
code and at least one prescription for gluten-free product), the
incidence patterns across age, sex, calendar year and socio-
economic status remained very similar to our main analyses. We
found that 80.8% of children with CD had a prescription for a
gluten-free product that was similar to the ﬁnding reported by
Hall et al.29 They conducted a questionnaire study of a sample
of patients with CD identiﬁed by Read codes in northeast
England, and while they conﬁrmed that all patients did have
CD disease, only 86.1% of their patients with CD obtained a
gluten-free prescription. We believe therefore that it is unlikely
that there has been any great amount of over-ascertainment of
CD in our study.
Moving on from our outcome to consider our principal
exposure measurement, the Townsend index is a validated
measure of how socioeconomically deprived an area is within
the UK based on standardised indicators. However, this score
Table 1 Incidence of coeliac disease (N=2 063 421)
Number of coeliac
disease cases Person-years
Rate per 100 000
person-years (95% CI)
Unadjusted incidence
rate ratios (95% CI)
Overall 1247 10 508 374 11.9 (11.2 to 12.5)
Sex
Male 514 5 448 627 9.4 (8.6 to 10.3) 1
Female 733 5 059 747 14.5 (13.5 to 15.6) 1.53 (1.37 to 1.72)
Age (years)
<1 24 599 728 4.0 (2.7 to 6.0)
1 125 668 994 18.7 (15.7 to 22.2)
2 119 662 631 17.9 (15.0 to 21.5)
3 91 653 575 13.9 (11.3 to 17.1)
4 97 643 093 15.1 (12.4 to 18.4)
5 67 629 754 10.6 (8.4 to 13.5)
6 81 618 239 13.1 (10.5 to 16.3)
7 74 608 210 12.1 (9.7 to 15.3)
8 66 597 770 11.0 (8.7 to 14.0)
9 64 587 151 10.9 (8.5 to 13.9)
10 62 576 655 10.7 (8.4 to 13.8)
11 55 566 426 9.7 (7.4 to 12.6)
12 56 554 291 10.1 (7.7 to 13.1)
13 58 539 042 10.7 (8.3 to 13.9)
14 65 521 484 12.4 (9.7 to 15.9)
15 43 507 872 8.4 (6.3 to 11.4)
16 43 495 529 8.6 (6.4 to 11.7)
17 57 477 930 11.9 (9.2 to 15.5)
Country
England 1003 8 194 945 12.2 (11.5 to 13.0) 1
Scotland 139 1 286 924 10.8 (9.1 to 12.7) 0.88 (0.73 to 1.05)
Wales 69 649 399 10.6 (8.4 to 13.4) 0.87 (0.68 to 1.10)
Northern Ireland 36 377 106 9.5 (6.9 to 13.2) 0.77 (0.55 to 1.08)
Calendar period
1993–1997 50 603 213 8.3 (6.3 to 10.9) 1
1998–2002 222 2 405 398 9.2 (8 to 1.10.5) 1.11 (0.82 to 1.51)
2003–2007 404 3 572 886 11.3 (10.2 to 12.5) 1.36 (1.01 to 1.83)
2008–2012 571 3 926 877 14.5 (13.4 to 15.8) 1.75 (1.31 to 2.34)
Socioeconomic deprivation (quintile of Townsend index)
1 (least deprived) 350 2 479 655 14.1 (12.7 to 15.7) 1.80 (1.45 to 2.22)
2 295 2 032 782 14.5 (12.9 to 16.2) 1.85 (1.48 to 2.30)
3 221 2 043 017 10.8 (9.5 to 12.3) 1.38 (1.09 to 1.73)
4 198 1 901 385 10.4 (9.0 to 11.9) 1.33 (1.05 to 1.67)
5 (most deprived) 110 1 402 742 7.8 (6.5 to 9.4) 1
Missing 73 648 793 11.2 (8.9 to 14.1) 1.43 (1.06 to 1.92)
CI, confidence interval.
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gives an overall deprivation index of the people living in a par-
ticular area of approximately 50 households, not taking into
account individual variation in deprivation levels or the differ-
ences between urban and rural areas. The small number of CD
cases registered in Wales and Northern Ireland reduced the stat-
istical power for these particular analyses.
The relationship between CD diagnosis and socioeconomic
grouping did not hold in the time period 1993–1997, which
could be related to the differences in diagnosis tools and clinical
presentation during that period compared with the following
ones. Diagnostic biopsies at that time were frequently carried
out by general paediatricians using Crosby or Watson capsules,
rather than requiring referral to a paediatric gastroenterologist
for endoscopic biopsy. Furthermore, only in the most recent
decades has there been a shift towards older average age at
diagnosis among children and altered clinical presentation30 (ie,
less distension, failure to thrive and more subtle symptomatol-
ogy).31 It is possible that these issues could have contributed to
the different diagnosis rates among socioeconomic groups that
we have observed. An alternative perspective is that the appar-
ently older age at diagnosis observed in various studies has been
driven by greater ascertainment and therefore earlier (younger)
diagnosis of older (>10 years of age) children. Finally, we
cannot exclude that the lack of a gradient seen in the period
1993–1997 was simply related to the lack of adequate sample
size during these years.
Comparison with previous literature
Socioeconomic status has been proposed as a possible factor in
the development of CD, although existing studies show
Table 2 Incidence of coeliac disease over time by sex and age and relative incidence in 2008–2012 compared with 1993–1997 (N=2 063 421)
Calendar period
Calendar year 1993–1997* 1998–2002* 2003–2007* 2008–2012*
Unadjusted IRR for
calendar period† (95% CI)
Sex
Male 7.8 (5.3 to 11.6) 7.7 (6.3 to 9.3) 9.3 (7.9 to 10.8) 10.9 (9.6 to 12.6) 1.39 (0.92 to 2.10)
Female 8.8 (5.9 to 12.9) 10.9 (9.2 to 13.0) 13.5 (11.8 to 15.3) 18.3 (16.5 to 20.3) 2.09 (1.39 to 3.13)
Age (years)
0–2 16.7 (11.5 to 24.1) 14.2 (11.1 to 18.0) 13.9 (11.3 to 17.3) 12.9 (10.4 to 15.8) 0.77 (0.50 to 1.18)
3–9 5.7 (3.4 to 9.7) 8.7 (7.1 to 10.7) 12.1 (10.4 to 14.0) 16.4 (14.5 to 18.6) 2.85 (1.66 to 4.88)
10–18 4.1 (2.1 to 8.8) 7.2 (5.6 to 9.2) 9.4 (7.9 to 11.1) 13.5 (11.8 to 15.4) 3.24 (1.60 to 6.56)
Country
England 8.9 (6.7 to 11.9) 9.9 (8.6 to 11.4) 11.7 (10.5 to 13.0) 14.8 (13.5 to 16.2) 1.65 (1.22 to 2.24)
Scotland – 5.1 (3.0 to 8.7) 11.2 (8.5 to 14.8) 14.3 (11.3 to 17.9) 2.77 (1.56 to 4.90)‡
Wales 11.0 (3.5 to 34.2) 9.2 (5.2 to 16.2) 10.3 (6.8 to 15.5) 11.5 (8.1 to 16.4) 1.04 (0.32 to 3.42)
Northern Ireland 5.9 (0.8 to 42.3) 6.3 (2.8 to 14.0) 5.3 (2.5 to 11.2) 16.4 (10.8 to 24.9) 2.76 (0.37 to 20.46)
Interaction tests: sex and calendar year, LRT p value=0.4; age group and calendar year, LRT p value<0.001; country and calendar year, LRT p value=0.05.
*Incidence rates of coeliac diseases per 100 000 person-years (95% CI).
†Comparing the latest with the earliest calendar period.
‡Since there were no incident coeliac disease cases in the Scottish practices between 1993 and 1997, we used the period 1998–2002 as baseline.
CI, confidence interval; IRR, incidence rate ratio; LRT, likelihood ratio test.
Table 3 Incidence of coeliac disease across socioeconomic groups (N=2 063 421)
Quintile of deprivation 1=least deprived* 2* 3* 4* 5=most deprived* Missing
Sex
Male 11.4 (9.7 to 13.4) 11.4 (9.5 to 13.6) 9.3 (7.7 to 11.4) 7.4 (5.9 to 9.3) 6.4 (4.8 to 8.5) 8.2 (5.6 to 11.9)
Female 17.0 (14.8 to 19.6) 17.9 (15.4 to 20.7) 12.4 (10.4 to 14.8) 13.6 (11.4 to 16.2) 9.4 (7.3 to 12.0) 14.4 (10.8 to 19.2)
Age (years)
0–2 15.6 (12.3 to 19.8) 18.5 (14.5 to 23.5) 14.4 (11.0 to 18.8) 10.4 (7.5 to 14.3) 9.3 (6.3 to 13.8) 13.1 (8.3 to 20.5)
3–9 14.6 (12.4 to 17.1) 15.7 (13.2 to 18.6) 9.9 (8.0 to 12.3) 11.9 (9.7 to 14.6) 8.3 (6.2 to 11.0) 11.9 (8.5 to 16.8)
10–18 13.0 (10.9 to 15.4) 11.6 (9.5 to 14.2) 10.1 (8.1 to 12.5) 8.9 (7.0 to 11.3) 6.7 (4.9 to 9.2) 9.2 (6.0 to 14.2)
Calendar period
1993–1997 8.2 (4.5 to 14.9) 5.3 (2.4 to 11.9) 10.5 (5.9 to 18.5) 8.1 (4.2 to 15.6) 4.7 (1.7 to 12.6) 16.4 (8.2 to 32.8)
1998–2002 12.3 (9.7 to 15.6) 10.0 (7.5 to 13.4) 8.6 (6.3 to 11.7) 8.2 (5.9 to 11.5) 5.2 (3.2 to 8.4) 8.2 (4.7 to 14.5)
2003–2007 12.6 (10.4 to 15.2) 14.8 (12.2 to 17.9) 11.4 (9.1 to 14.2) 9.3 (7.2 to 12.0) 7.6 (5.5 to 10.6) 8.5 (5.4 to 13.5)
2008–2012 17.4 (14.9 to 20.4) 18.4 (15.5 to 21.7) 11.7 (9.5 to 14.3) 13.0 (10.6 to 16.0) 10.2 (7.8 to 13.3) 14.4 (10.3 to 20.0)
Country
England 14.2 (12.7 to 15.9) 14.7 (12.9 to 16.7) 11.1 (9.6 to 12.8) 10.9 (9.3 to 12.7) 8.0 (6.4 to 9.9) 11.9 (9.2 to 15.4)
Scotland 12.6 (8.2 to 19.1) 17.0 (12.7 to 22.7) 9.6 (6.4 to 14.5) 8.2 (5.4 to 12.6) 7.1 (4.5 to 11.3) 9.2 (4.8 to 17.8)
Wales 14.4 (9.2 to 22.6) 10.2 (6.0 to 17.3) 9.1 (5.3 to 15.6) 11.4 (6.9 to 18.5) 7.2 (3.2 to 16.0) 7.3 (1.0 to 51.9)
Northern Ireland 13.1 (6.2 to 24.2) 7.8 (3.2 to 18.8) 11.3 (5.7 to 22.7) 4.1 (1.0 to 14.4) 9.1 (4.1 to 20.4) 9.6 (4.0 to 23.1)
*Incidence rates of coeliac diseases per 100 000 person-years (95% CIs).
CI, confidence interval.
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contradictory results. As table 5 shows, these studies have
several differences in study design, outcome, exposure deﬁn-
ition, study population and setting. Most of them were con-
ducted using groups of already-diagnosed patients with CD,12–
19 and the only two population-based studies consider patients
detected by serological screening rather than clinical diagno-
sis.20 21 Three studies have been conducted in different areas of
the UK on children.14 15 18 Whyte et al14 reported a higher risk
of CD diagnosis in children, aged <16 years, belonging to the
least-deprived areas compared with those from the most-
deprived areas in South Wales, which is similar to our results.
This cross-sectional study used The Welsh Index of Multiple
Deprivation as a measure of the socioeconomic status that is
comparable to the Townsend index. Conversely, a small Scottish
cohort study15 found no large difference between the Standard
Index of Multiple Deprivation and urban/rural indices in chil-
dren with CD and the general population in Scotland. In 2009,
Robert et al18 reported that in an area of the South of England
children from manual social classes IV and V had a fourfold
increased risk of CD compared with those from professional
social classes I and II. Finally, looking at all ages in the UK
population, our recent population-based study, using the
Table 4 Adjusted incidence rate ratios for the association of coeliac disease with socioeconomic status, stratified by sex, age, calendar period
and country (N=2 063 421)
Quintile of deprivation 1=least deprived* 2* 3* 4*
5=most
deprived
p Value
for trend** Missing*
Sex‡
Male 1.76 (1.26 to 2.46) 1.78 (1.26 to 2.50) 1.45 (1.02 to 2.06) 1.15 (0.79 to 1.66) 1 <0.001 1.26 (0.78 to 2.03)
Female 1.79 (1.35 to 2.37) 1.89 (1.42 to 2.52) 1.30 (0.96 to 1.77) 1.44 (1.06 to 1.94) 1 <0.001 1.51 (1.03 to 2.20)
Age (years)§
0–2 1.57 (0.99 to 2.48) 1.92 (1.21 to 3.04) 1.48 (0.92 to 2.38) 1.08 (0.65 to 1.79) 1 0.004 1.38 (0.76 to 2.51)
3–9 1.70 (1.22 to 2.36) 1.86 (1.33 to 2.59) 1.17 (0.82 to 1.67) 1.41 (0.99 to 2.01) 1 <0.001 1.43 (0.91 to 2.23)
10–18 1.97 (1.37 to 2.83) 1.74 (1.19 to 2.53) 1.52 (1.03 to 2.23) 1.35 (0.90 to 2.00) 1 <0.001 1.39 (0.82 to 2.37)
Calendar period†
1993–1997 1.47 (0.49 to 4.63) 1.00 (0.28 to 3.56) 1.98 (0.63 to 6.15) 1.58 (0.49 to 5.14) 1 0.95 3.14 (0.94 to 10.50)
1998–2002 2.22 (1.31 to 3.79) 1.87 (1.10 to 3.25) 1.59 (0.90 to 2.81) 1.55 (0.87 to 2.76) 1 0.001 1.54 (0.73 to 3.24)
2003–2007 1.63 (1.11 to 2.38) 1.92 (1.31 to 2.81) 1.48 (1.00 to 2.20) 1.21 (0.81 to 1.83) 1 <0.001 1.11 (0.63 to 1.97)
2008–2012 1.71 (1.25 to 2.34) 1.81 (1.31 to 2.48) 1.15 (0.81 to 1.61) 1.28 (0.92 to 1.80) 1 <0.001 1.39 (0.91 to 2.13)
Country¶
England 1.79 (1.04 to 2.30) 1.86 (1.44 to 2.39) 1.39 (1.07 to 1.82) 1.37 (1.04 to 1.79) 1 <0.001 1.47 (1.05 to 2.06)
Scotland 1.66 (0.89 to 3.10) 2.23 (1.29 to 3.86) 1.26 (0.68 to 2.34) 1.11 (0.59 to 2.08) 1 0.004 1.21 (0.54 to 2.71)
Wales 2.02 (0.81 to 5.07) 1.43 (0.55 to 3.73) 1.26 (0.48 to 3.34) 1.58 (0.62 to 4.05) 1 0.188 0.95 (0.11 to 7.91)
Northern Ireland 1.45 (0.53 to 4.00) 0.85 (0.26 to 2.80) 1.20 (0.41 to 3.46) 0.44 (0.08 to 2.20) 1 0.340 1.21 (0.36 to 4.06)
Interaction tests: sex and socioeconomic status, LRT p value=0.67; age group and socioeconomic status, LRT p value 0.78; calendar years and socioeconomic status, LRT p value=0.42;
countries and socioeconomic status, LRT p value=0.87.
*Incidence rate ratio compared with most deprived (5th quintile).
Adjusted for: ‡Age and calendar period and country;
§Sex and calendar period and country;
†Sex and age and country;
¶Sex and calendar period and age.
**Excluding missing data.
LRT, likelihood ratio test.
Figure 1 Coeliac disease incidence across countries of the UK according to socioeconomic group. CD, coeliac disease; CI, conﬁdence interval.
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Table 5 Previous literature on the association between socioeconomic status and coeliac disease
Geographic area Study population
Source of the outcome
N=number of cases Source of socioeconomic status Main findings
Diagnosed CD (serology and/or biopsy-positive cases) within medical settings
Burger et al12 Netherlands Subjects identified into the Dutch Pathology
Registry, which covers all pathology labs in
Netherlands 1995–2010
N= 6444
CD diagnosis according to biopsy reports
N=4014
The socioeconomic status scores based on income, level
of education and employment
Patients diagnosed with CD during childhood were
more often from an area with a higher
socioeconomic status compared with patients
diagnosed later in life (p<0.001)
West et al13 The UK All ages UK population registered with the
Clinical Practice Research Datalink—
1990–2011
N=65 856 848 person-years
People with Read codes representing CD ( J690.00;
J690.13; J690z00; J690100; J690.14; J690000)
N=9087
Indices of Multiple Deprivation The CD incidence was 27% lower in people from the
most-deprived areas than in people from the
least-deprived ones (IRR 0.83, 95% CI 0.77 to 0.89)
Whyte et al14 Cardiff, Newport
and Powys (South
Wales)
The total paediatric population (age <16) in
South Wales (UK national census 2008)
N=298 530 children
CD diagnosis according to ESPGHAN 1990 criteria in the
same tertiary medical centre between 1995 and 2012
N=232
Welsh Index of Multiple Deprivation The prevalence of CD in the lowest deprivation level
was 1.16/1000 and 0.49/1000 in the highest
deprivation level
White et al15 Southeast
Scotland
The total paediatric population (age <16) in
Southeast Scotland—1990–2009 (Scotland
census)
N=∼225 000 children
CD diagnosis according to ESPGHAN 1990 criteria. Data
from hospital records (ICD codes of CD), paediatric
pathology records, regional clinical database, regional
serology database and the electronic hospital record
N=266
The Scottish government data for the Standard Index of
Multiple Deprivation and urban/rural indices
The median of the Standard Index of Multiple
Deprivation score and urban–rural classification
indices of patients with CD were comparable to the
general population of southeastern Scotland
Olén et al16 Sweden Individuals aged 16–64 years using the Total
Population Register
1969–2008
N=174 186 subjects
CD diagnosis according to biopsy reports collected from
all Swedish pathology departments
N=29 096
European Socioeconomic Classification based on
occupation.
Data collected using The Swedish Occupational Register
Individuals from the lowest social class were 11%
less likely to be diagnosed with CD (OR 0.89, 95%
CI 0.84 to 0.94)
Wingren
et al17
Sweden Prospective evaluation of babies born in
Sweden between 1987 and 1993 (follow-up
2 years)
N=392 568 men and 372 112 women
The Swedish National Hospital Discharge Registry
according to ICD codes of CD
N=845 in men and 1401 in women
Information on the mothers’ pre-tax equalised household
income and social allowance for the year before delivery
(five classes)
Boys born to mothers in an overt low socioeconomic
position had a higher risk of CD (OR 1.37, 95% CI
1.03 to 1.82) than those with mothers with high
income and no social allowance
Robert et al18 South East
England
Babies born in the south east of England
between 1970 and 1999 (mean follow-up
duration 18 years) using the Oxford record
linkage study database having linked
maternity data in the same dataset
N=248 521
Children with both a maternity record and a subsequent
admission for CD (ICD codes of CD) in the Oxford record
linkage study database
N=90
Information collected from maternal records in the
Oxford record linkage study database
Children from manual social classes IV and V had a
4.02 increased risk of coeliac disease (95% CI1.96
to 8.25) compared with those from professional
social classes I and II
Ludvigsson19 Sweden Babies born in southeast Sweden between
1997 and 1999 (follow-up 15 years)
N=15 875 single births
Coeliac cases reported by eight paediatric departments
A case was included if he had intestinal biopsy
suggesting CD, no symptoms after the introduction of a
gluten-free diet and/or no or only minor
histopathological abnormalities consistent with CD at
the control biopsy under treatment with gluten-free diet
N=45
Information collected in questionnaire completed by the
mothers shortly after childbirth on: place of living 1 year
before conception, maternal employed during pregnancy,
paternal employed the year before the conception, family
crowed living
CD was less common in mothers who had worked
<3 months during pregnancy (OR=0.29; 95% CI
0.09 to 0.94; p=0.039). The other socioeconomic
factors were not associated
Screening detected CD in the general population
Kondrashova
et al20
Finland and
Russia
Schoolchildren
Russia Karelia: age ranged 6.2–18.3 years
(1997–2001)
N=1988 children
Northern Finland: age ranged 7–18 years
(1994)
N= 3654 children
Serological screening by tTGA
All subjects who were positive were offered an intestinal
biopsy to confirm CD diagnosis.
N=4 in Russia and 34 in Finland
Comparison between two areas with opposite
socioeconomic condition (poor Russia vs rich Finland).
0.6% of the children (12/1988; CI 0.3% to 1.1%) in
Russian Karelia tested positive for tTGA compared
with 1.4% (52/3654; CI 1.1% to 1.9%) in the
Finnish cohort. Biopsy-proven CD: N=4 in Russia and
34 in Finland (no biopsy in 13 subjects)
West et al21 Cambridge Participants, age 45–76 years registered with
a general practice in Cambridge, England
(1990–1995)
N=7527
Serological screening by EMA
N=87
Participant-reported occupation categorised as
professional, skilled, unskilled/partly skilled
EMA positivity less common in partly skilled or
unskilled workers, as compared to professionals
(OR 0.51, 95% CI 0.18 to 1.43)
CD, coeliac disease; EMA, antiendomisial antibody; ESPGHAN, European Society of Paediatric Gastroenterology, Hepatology and Nutrition; ICD, international classification of disease; IRR, incident rate ratio; tTGA, IgA antitransglutaminase.
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Clinical Practice Research Database,13 also described that CD
occurred more commonly in areas with the least socioeconomic
deprivation. Outside the UK, three Swedish studies16 17 19 have
reported contradictory results on the association between socio-
economic status and CD (table 5). Similarly to our results,
Burger et al12 have recently described, using registered path-
ology reports in the Netherlands, that patients diagnosed in
childhood were more often from higher socioeconomic status
compared with patients diagnosed later in life.
Interpretation
It is not possible from this study nor from previous literature to
conclusively explain the reasons for this gradient, which may
indicate either that the ascertainment of disease varies among
social classes or that there is a true variation in incidence by
socioeconomic status. For example, individuals from more-
deprived areas may be less likely to seek medical care or consult-
ation in general and thus be potentially less likely to be tested
for CD.10 32 33 Aside from ascertainment, however, it is also
possible that people of different socioeconomic groups are
exposed to different risk factors, which might indirectly contrib-
ute to CD development. Two studies of screening-detected CD
(table 5), one in the UK showing a weak socioeconomic gradi-
ent21 and the other reporting a higher prevalence of detected
CD in children from Finland than in those from a more socio-
economically deprived Russian area,20 may support this conjec-
ture. The duration of exclusive breast feeding and the optimal
timing of gluten introduction for infants in terms of their con-
tribution to the risk of developing CD have been debated for
several years. Previous studies have implied a window of
time (4–6 months of age) during which the introduction of
gluten might facilitate induction of tolerance (window of toler-
ance);34–38 however, evidence from two newly published clinical
trials has not conﬁrmed this.39 40 Vriezinga et al recruited
HLA-DQ2 or HLADQ8-positive newborns with a ﬁrst-degree
relative affected by CD from eight countries and showed no dif-
ference in the risk of CD by 3 years of age between infants ran-
domised to 100 mg of immunologically active gluten daily
(combined with lactose) and those given a placebo (lactose only)
between 4 and 6 months.39 Furthermore, they observed no asso-
ciation of breastfeeding duration, regardless of whether it was
exclusive or with gluten introduction, with CD development.
Lionetti et al40 conducted a trial in Italy of predisposed new-
borns (those with a ﬁrst-degree relative with CD) and found
that the introduction of gluten at 12 months vs 6 months
slightly delayed the onset of CD, but CD prevalence was no dif-
ferent by 5 years of age. In addition, the authors did not detect
any effect of breast feeding on the development of CD. These
trials do not support the possibility that differences in time of
gluten introduction or breastfeeding duration explain the socio-
economic gradient we observed in our population. Furthermore,
an analysis of breast feeding in England showed a lower preva-
lence of exclusive breast feeding at 6–8 weeks postdelivery
among women from the most-deprived areas than in the least-
deprived areas.41 Since the higher incidence of CD in children
from less-deprived groups that we observed is opposite to the
relationship this would be expected to cause, this is further evi-
dence that known differences in breast feeding are unlikely to
explain the socioeconomic gradient of CD.
Another potential explanation of the observed socioeconomic
gradient could be related to the so-called hygiene hypothesis.42
This hypothesises that a decreased antigenic exposure in child-
hood in less-deprived groups causes an immunological over-
reaction at the time of a subsequent antigenic contact,42 43 that
is, gluten in the case of CD. A greater exposure to childhood
infection may also occur in children of lower socioeconomic
groups,44 which could eventually protect them from later devel-
opment of CD via this mechanism. This explanation, however,
is inconsistent with previous evidence of early infections as a
potential risk factor for CD.45 46 Lastly, little is known about
dietary variation in gluten according to socioeconomic group,47
so we cannot speculate whether this may play a role.48
CONCLUSION
Based on the current evidence, the most plausible explanation
for the socioeconomic gradient in the incidence of childhood
CD whereby children from least-deprived areas have CD diag-
nosed more often than those from the most-deprived areas is
that ascertainment of disease varies rather than the true occur-
rence of CD. Awareness campaigns and the implementation of
diagnostic guidelines may help to implement strategies for case-
ﬁnding in all children and reduce this inequality. Moreover, a
greater use of the new paediatric guidelines49 50 with the possi-
bility to diagnose symptomatic cases without biopsy might
increase the access to diagnosis in children from the most-
deprived areas. Future studies might continue to explore the
possible association between exposures to different speciﬁc risk
factors with the occurrence of CD across socioeconomic groups.
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